These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 8289843)

  • 1. [Expression of the vif gene of human immunodeficiency virus type 1 in Escherichia coli and study of the immunoreactivity of the vif protein].
    Karaseva NG; Gibadulin RA; Kiselev SI; Karamov EV
    Mol Gen Mikrobiol Virusol; 1993; (5):26-9. PubMed ID: 8289843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cooperative and specific binding of Vif to the 5' region of HIV-1 genomic RNA.
    Henriet S; Richer D; Bernacchi S; Decroly E; Vigne R; Ehresmann B; Ehresmann C; Paillart JC; Marquet R
    J Mol Biol; 2005 Nov; 354(1):55-72. PubMed ID: 16236319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The use of the vif gene expression product of HIV-1 in bacteria for detecting specific antibodies in the sera of infected persons].
    Zverev SIa; Bobkov AF; Garaev MM
    Vopr Virusol; 1992; 37(1):16-9. PubMed ID: 1413707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a nuclear transport inhibitory signal (NTIS) in the basic domain of HIV-1 Vif protein.
    Friedler A; Zakai N; Karni O; Friedler D; Gilon C; Loyter A
    J Mol Biol; 1999 Jun; 289(3):431-7. PubMed ID: 10356319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral and cellular specificities of caprine arthritis encephalitis virus Vif protein.
    Seroude V; Audoly G; Gluschankof P; Suzan M
    Virology; 2002 Jan; 292(1):156-61. PubMed ID: 11878918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abrogation of Vif function by peptide derived from the N-terminal region of the human immunodeficiency virus type 1 (HIV-1) protease.
    Hutoran M; Britan E; Baraz L; Blumenzweig I; Steinitz M; Kotler M
    Virology; 2004 Dec; 330(1):261-70. PubMed ID: 15527851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic characterization of vif, vpr, and vpu sequences from long-term survivors of human immunodeficiency virus type 1 infection.
    Zhang L; Huang Y; Yuan H; Tuttleton S; Ho DD
    Virology; 1997 Feb; 228(2):340-9. PubMed ID: 9123841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV accessory genes Vif and Vpu.
    Strebel K
    Adv Pharmacol; 2007; 55():199-232. PubMed ID: 17586316
    [No Abstract]   [Full Text] [Related]  

  • 9. Changes in the Vif protein of HIV-1 associated with the development of resistance to inhibitors of viral protease.
    Adekale MA; Cane PA; McCrae MA
    J Med Virol; 2005 Feb; 75(2):195-201. PubMed ID: 15602725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptides derived from HIV-1 Vif: a non-substrate based novel type of HIV-1 protease inhibitors.
    Friedler A; Blumenzweig I; Baraz L; Steinitz M; Kotler M; Gilon C
    J Mol Biol; 1999 Mar; 287(1):93-101. PubMed ID: 10074409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant technology as an alternative to chemical peptide synthesis: expression and characterization of HIV-1 Rev recombinant peptides.
    Lepage P; Heckel C; Humbert S; Stahl S; Rautmann G
    Anal Biochem; 1993 Aug; 213(1):40-8. PubMed ID: 8238880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinational analysis of a natural noncytopathic human immunodeficiency virus type 1 (HIV-1) isolate: role of the vif gene in HIV-1 infection kinetics and cytopathicity.
    Sakai K; Ma XY; Gordienko I; Volsky DJ
    J Virol; 1991 Nov; 65(11):5765-73. PubMed ID: 1920615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unimpaired function of a naturally occurring C terminally truncated vif gene product of human immunodeficiency virus type 1.
    Ochsenbauer C; Bosch V; Oelze I; Wieland U
    J Gen Virol; 1996 Jul; 77 ( Pt 7)():1389-95. PubMed ID: 8757978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A specific inhibitor of cysteine proteases impairs a Vif-dependent modification of human immunodeficiency virus type 1 Env protein.
    Guy B; Geist M; Dott K; Spehner D; Kieny MP; Lecocq JP
    J Virol; 1991 Mar; 65(3):1325-31. PubMed ID: 1995946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The tyrosine kinase Hck is an inhibitor of HIV-1 replication counteracted by the viral vif protein.
    Hassaïne G; Courcoul M; Bessou G; Barthalay Y; Picard C; Olive D; Collette Y; Vigne R; Decroly E
    J Biol Chem; 2001 May; 276(20):16885-93. PubMed ID: 11278465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of lysine to arginine mutations in HIV-1 Vif on its expression and viral infectivity.
    Khamsri B; Fujita M; Kamada K; Piroozmand A; Yamashita T; Uchiyama T; Adachi A
    Int J Mol Med; 2006 Oct; 18(4):679-83. PubMed ID: 16964423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the cell-dependent replication potentials of human immunodeficiency virus type 1 vif mutants.
    Fujita M; Sakurai A; Doi N; Miyaura M; Yoshida A; Sakai K; Adachi A
    Microbes Infect; 2001 Nov; 3(13):1093-9. PubMed ID: 11709289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An improved method for purification and refolding of recombinant HIV Vif expressed in Escherichia coli.
    Duarte CA; Palomino M
    Biotechnol Appl Biochem; 2018 Mar; 65(2):195-202. PubMed ID: 28181316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diversity of the vif gene of human immunodeficiency virus type 1 in Uganda.
    Wieland U; Seelhoff A; Hofmann A; Kühn JE; Eggers HJ; Mugyenyi P; Schwander S
    J Gen Virol; 1997 Feb; 78 ( Pt 2)():393-400. PubMed ID: 9018062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Vif protein of human immunodeficiency virus type 1 is posttranslationally modified by ubiquitin.
    Dussart S; Courcoul M; Bessou G; Douaisi M; Duverger Y; Vigne R; Decroly E
    Biochem Biophys Res Commun; 2004 Feb; 315(1):66-72. PubMed ID: 15013426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.